Apontis Pharma AG Cash Flow-to-Debt Ratio
Apontis Pharma AG cash flow-to-debt ratio. Apontis Pharma AG (APPH) has a Cash Flow-to-Debt Ratio of -0.16x as of June 2025, meaning its operating cash flow of €-1.94 Million could theoretically repay 0% of its total liabilities (€12.37 Million) in one year. Check Apontis Pharma AG cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Apontis Pharma AG (2019–2024)
Cash flow-to-debt ratio of Apontis Pharma AG from 2019 to 2024. Historical debt coverage capacity for Apontis Pharma AG across 6 annual periods. Check cash flow reinvestment rate of Apontis Pharma AG to assess the company's total reinvestment commitment from operating cash flow.
Apontis Pharma AG Cash Flow-to-Debt Ratio by Year (2019–2024)
Apontis Pharma AG cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Apontis Pharma AG. For the full cash flow conversion analysis, see APPH cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.22x | €-2.90 Million | €13.36 Million | ▲ +53.1% |
| 2023 | -0.46x | €-12.60 Million | €27.20 Million | ▼ -176.9% |
| 2022 | 0.60x | €11.02 Million | €18.29 Million | ▲ +135.5% |
| 2021 | 0.26x | €3.43 Million | €13.42 Million | ▲ +362.5% |
| 2020 | 0.06x | €1.45 Million | €26.23 Million | ▲ +702.8% |
| 2019 | -0.01x | €-238.07K | €25.94 Million | — |